Biblio
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases. PLoS One. 2013;8(9):e74548.
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. Semin Cancer Biol. 2019.
.